Deferred Tax Assets, Net of Valuation Allowance of AYTU BIOPHARMA, INC from 30 Jun 2020 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: AYTU BIOPHARMA, INC quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 30 Jun 2020 to 30 Jun 2025.
AYTU BIOPHARMA, INC Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Jun 2025 was $252,000, a 67% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

AYTU BIOPHARMA, INC Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$252,000	-$510,000	-67%	30 Jun 2025	10-K	23 Sep 2025	2025	FY
Q2 2024	$762,000	-$616,000	-45%	30 Jun 2024	10-K	23 Sep 2025	2025	FY
Q2 2023	$1,378,000	-$2,308,000	-63%	30 Jun 2023	10-K	26 Sep 2024	2024	FY
Q2 2022	$3,686,000	-$7,221,000	-66%	30 Jun 2022	10-K	12 Oct 2023	2023	FY
Q2 2021	$10,907,000	+$9,105,000	+505%	30 Jun 2021	10-K	27 Sep 2022	2022	FY
Q2 2020	$1,802,000			30 Jun 2020	10-K	28 Sep 2021	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.